---
title: "Prenosis secures $20M BARDA contract & $20M Series A funding, advancing innovation in critical care diagnostics & therapeutics."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274173369.md"
description: "Prenosis has secured a $20 million contract with BARDA and $20 million in Series A funding, aimed at enhancing innovation in critical care diagnostics and therapeutics. The company, based in Chicago, focuses on biology-based solutions for critical care conditions. These developments, announced on January 29, 2026, are expected to accelerate advancements in healthcare, particularly in diagnostics and therapies for critical care needs."
datetime: "2026-01-29T15:07:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274173369.md)
  - [en](https://longbridge.com/en/news/274173369.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274173369.md)
generator: "portal-rs"
---

# Prenosis secures $20M BARDA contract & $20M Series A funding, advancing innovation in critical care diagnostics & therapeutics.

Prenosis, a cutting-edge technology company focusing on biology-based diagnostics and therapeutics for critical care conditions, has recently made significant progress through its latest fundraising endeavors in Chicago. The company, which aims to revolutionize healthcare through integrated solutions, unveiled two key announcements on January 29, 2026. This successful round of funding is set to accelerate innovation in the field, with a focus on developing advanced diagnostics and therapies to address critical care needs. Keep an eye on Prenosis as they continue to drive forward in this essential sector.

### Related Stocks

- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [GNPX.US](https://longbridge.com/en/quote/GNPX.US.md)
- [PRENW.US](https://longbridge.com/en/quote/PRENW.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)

## Related News & Research

- [EverGen Infrastructure Reports Q2 2026 Results | EVGIF Stock News](https://longbridge.com/en/news/297122882.md)
- [Biotech Stocks Facing FDA Decision In September 2026](https://longbridge.com/en/news/297065559.md)
- [SBIO: U.S. Programmatic and EMEA drove 49% of Q2 sales, with margins rising to 61% and profitability expected in H2 2026](https://longbridge.com/en/news/296517769.md)
- [Guotai Asset Management sees liquidity boost driving China biotech, innovation drug shares higher](https://longbridge.com/en/news/296448906.md)
- [Moderna surges on trial win for cancer shot; William Blair upgrades](https://longbridge.com/en/news/296370751.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**